10/4/2013

New guidance from the FDA outlines the information medtech manufacturers should supply to the agency when seeking investigational device exemption approval to carry out early feasibility trials. The guidance also details the requirements involving changes made to study protocols or device designs during the feasibility trial.

Related Summaries